Effect of Biolimus-Eluting Stents With B...

In part 2 of this Healthy Dialogue on breast cancer, Nancy E. Davidson, MD, discusses changes in screening, the patient journey, and what may lie ahead with advances in AI, cancer vaccines, and preventive medicine. Correction: a previous version of this podcast incorrectly identi ... Show More

Breast cancer has undergone a dramatic transformation over the past several decades. Five-year survival rates are now 92% compared with 76% in 1975. In this special 2-part episode of Healthy Dialogue, Nancy E. Davidson, MD, oncologist and chief academic officer and executive vice ... Show More

Approximately 1 in 5 Americans live in rural areas, and in the coming years they will see dramatic shifts in their health care options due to the One Big Beautiful Bill Act. In this episode of Healthy Dialogue Mark Holmes, PhD, joins host Derek C. Angus, MD, MPH, to explore the i ... Show More

Dr. Linda Chu speaks with Dr. Daniele Andreini about the Advantage II Study, which evaluates the accuracy of dynamic stress myocardial CT perfusion in patients with coronary artery stents. They discuss how this technique compares to invasive testing, its advantages over static CT ... Show More

In this episode, Dr. Valentin Fuster discusses the findings of a major randomized trial examining the use of drug-coated balloons (DCB) in treating side branch stenosis during coronary bifurcation procedures. The study suggests that DCBs offer better one-year outcomes compared to ... Show More

In this episode of Audible Bleeding, Jamila, Anh, and Naveed discuss the LifeBTK Trial with Principal Investigator Dr. Brian DeRubertis, where we discuss the new Abbott Esprit everolimus-eluting resorbable scaffold for the below-knee popliteal space. Guest: Dr. DeRubertis, is the ... Show More

ESC Recap Part 2: ECLS-SHOCK, FIRE, MULTISTARS-AMI, HEART FID, and DANPACE II are the trials John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit: https://www.medscape.co ... Show More

Dr. Seemant Chaturvedi discusses AtRial Cardiopathy and Antithrombotic Drugs in Prevention after Cryptogenic Stroke Randomized Trial [ARCADIA]. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. 

Dr. Steven Nissen, Chief Academic Officer, Sydell and Arnold Miller Family Heart & Vascular Institute talks with Dr. Serg Harb, a staff imaging cardiologist about the innovative diagnostic tool of 3D Printing – What are the clinical uses? Limitations? Research findings and future ... Show More

What are the clinical challenges in the use of biomarkers to estimate the risk of a cardiovascular event? Join Dr Bruna Gigante (Karolinska Institute, Solna, SE) in a discussion of potential biomarkers which may impact a patient’s cardiovascular risk profile. In this month’s feat ... Show More

Today, on the Nutrition Facts podcast, we look at stents — those tiny tubes that doctors insert into a blocked artery to keep it open. This episode features audio from Do Angioplasty Heart Stent Procedures Work? and Why Angioplasty Heart Stents Don’t Work Better. Visit the video ... Show More

When to use an ICD, risk stratification for HCM, blending EP and structural cardiology to improve care in post-TAVI patients, and hsTroponins are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a ... Show More